-
Sage Therapeutics' (SAGE) "Neutral" Rating Reiterated at HC Wainwright
Source: Buzz FX / 12 Feb 2025 08:41:10 America/New_York
Sage Therapeutics' (SAGE) "Neutral" Rating Reiterated at HC Wainwright Written by MarketBeat February 12, 2025 Share Link copied to clipboard. Sage Therapeutics ( NASDAQ:SAGE - Get Free Report ) 's stock had its "neutral" rating reaffirmed
Read more...